Neovascular Age-Related Macular Degeneration (NVAMD)

3 clinical trials · Condition

Record	Firm	Date
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO (NCT07205887)	EyeBiotech Ltd.	2025-09-12
A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration (NCT06664502)	EyeBiotech Ltd.	2024-11-12
A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (NCT05919693)	EyeBiotech Ltd.	2023-06-12

Every clearance here is in the API, with alerts when new ones post.